These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21382861)

  • 21. Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.
    Mai W; Hu X; Lu Z; Peng F; Wang Y
    J Int Med Res; 2011; 39(6):2402-13. PubMed ID: 22289560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
    Lee J; McKinney KQ; Pavlopoulos AJ; Han MH; Kim SH; Kim HJ; Hwang S
    Clin Chim Acta; 2016 Nov; 462():118-126. PubMed ID: 27609124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromyelitis optica.
    Feingold RM
    J Insur Med; 2008; 40(2):136-40. PubMed ID: 19119594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuromyelitis optica (Devic's disease): a severe variant of multiple sclerosis].
    Neuteboom RF; Garssen MP; Hintzen RQ
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1097-102. PubMed ID: 15198064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
    Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis.
    Layh-Schmitt G; Bendl C; Hildt U; Dong-Si T; Jüttler E; Schnitzler P; Grond-Ginsbach C; Grau AJ
    Ann Neurol; 2000 May; 47(5):652-5. PubMed ID: 10805338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
    Dujmovic I; Mader S; Schanda K; Deisenhammer F; Stojsavljevic N; Kostic J; Berger T; Drulovic J; Reindl M
    J Neuroimmunol; 2011 May; 234(1-2):124-30. PubMed ID: 21316112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Pellkofer HL; Krumbholz M; Berthele A; Hemmer B; Gerdes LA; Havla J; Bittner R; Canis M; Meinl E; Hohlfeld R; Kuempfel T
    Neurology; 2011 Apr; 76(15):1310-5. PubMed ID: 21482945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Devic's neuromyelitis optica: clinical and imaging findings.
    Vandevyver V; Lemmerling M; De Potter R; Verstraete K
    JBR-BTR; 2007; 90(4):284-7. PubMed ID: 17966247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the spectrum of neuromyelitis optica: friend or foe?
    Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
    Frohman EM; Kerr D
    Arch Neurol; 2007 Jun; 64(6):903-5. PubMed ID: 17562944
    [No Abstract]   [Full Text] [Related]  

  • 36. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
    Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
    Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
    Nakashima I; Fujinoki M; Fujihara K; Kawamura T; Nishimura T; Nakamura M; Itoyama Y
    Ann Neurol; 2007 Aug; 62(2):197-200; discussion 205. PubMed ID: 16958112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram].
    Limongi JC; Machado LR; Spina-França A
    Arq Neuropsiquiatr; 1981 Sep; 39(3):296-300. PubMed ID: 6119970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders?
    Bennett JL; Owens GP
    Ann Neurol; 2012 May; 71(5):587-8. PubMed ID: 22522475
    [No Abstract]   [Full Text] [Related]  

  • 40. IFNβ-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
    Bomprezzi R; Powers JM; Shimizu J; Tsuji S; Weinshenker BG; Wingerchuk DM
    Neurology; 2011 Jul; 77(2):195; discussion 195-6. PubMed ID: 21747078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.